We bring you the latest news from the healthcare about the health care in the United Kingdom.

maandag 1 oktober 2018

Blood Cancer Journal - Table of Contents alert Volume 8 September 2018

If you are unable to see the message below, click here to view.
Blood Cancer Journal

Advertisement
Register for the latest nature.com webcast

scDNA Analysis: Resolving Tumor Heterogeneity with Implications for Dynamic Therapy 

Researchers discuss their findings in a study of the FLT3 inhibitor gilteritinib in relapsed/refractory AML and how scDNA analysis may enable dynamic therapy selection.

Register for FREE today

Sponsored by Mission Bio
TABLE OF CONTENTS

Volume 8 (September 2018)

In this issue
Correspondence
 

Correspondence

 

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib

Oliver Ottmann, Giuseppe Saglio, Jane F. Apperley, Christopher Arthur, Eduardo Bullorsky et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0122-3

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Blood Cancer Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature